华丰科技回复称，公司224G高速背板连接器已达到样品试制合格的状态，为量产稳定性作技术积累， 具体量产时间取决于客户需求。112G高速背板产品已进入批量生产阶段，具体产能情况请关注后续的 相关公告。 格隆汇2月27日｜有投资者在互动平台向华丰科技提问：请问公司目前112G和224G高速连接器的实际产 能分别是多少？ ...

证券日报网讯2月26日，华丰科技在互动平台回答投资者提问时表示，公司224G高速背板连接器已达到 样品试制合格的状态，为量产稳定性作技术积累，具体量产时间取决于客户需求。112G高速背板产品 已进入批量生产阶段，具体产能情况请关注后续的相关公告。 ...

Group 1 - The company has completed customer validation testing for its 224G high-speed backplane connector and has samples available [1] - The company has initiated project cooperation and communication with major telecommunications customers, with mass production timing dependent on customer demand [1]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1][14] Core Insights - The company is expected to achieve a net profit attributable to shareholders of between 338 million and 388 million yuan in 2025, marking a turnaround from losses and representing a year-on-year increase of approximately 356 million to 406 million yuan, which is about 4.67 to 5.36 times the net profit of 2023 [6][7] - The anticipated net profit for Q4 2025 is projected to be between 115 million and 165 million yuan, reflecting a year-on-year growth of 272% to 434% [6][7] - The growth is primarily driven by the integration of artificial intelligence, cloud computing, and big data technologies, which are fueling a surge in demand for key equipment such as switches, AI servers, and core routers [7] Financial Projections - Revenue projections for 2025, 2026, and 2027 are 2.573 billion, 3.788 billion, and 5.120 billion yuan respectively, with growth rates of 136%, 47%, and 35% [12][13] - The net profit attributable to shareholders is expected to be 370 million, 672 million, and 876 million yuan for the same years, with growth rates of 2182%, 82%, and 30% [12][13] - The earnings per share (EPS) are projected to be 0.80, 1.46, and 1.90 yuan for 2025, 2026, and 2027 respectively [12][13] Market Position and Strategy - The company is actively collaborating with major manufacturers and internet application clients in the AI and data center sectors, including partnerships with Inspur, Huawei, and Tencent [8] - In the electric vehicle sector, the company has expanded its client base to include major players such as SAIC-GM-Wuling and BYD, as well as new clients like FAW Bestune and Geely [9] - The company is focusing on expanding its production capacity in technology innovation fields, particularly in AI, defense, commercial aerospace, and communications [10] Investment and Growth Initiatives - The company plans to invest 4.5 billion yuan in a high-speed line module project, which is expected to be a core component of AI computing servers, with a construction period of six months [11] - An investment of 470 million yuan is allocated for the construction of a defense connector base, aimed at enhancing R&D and manufacturing capabilities for various applications [11] - A project to upgrade communication connector R&D capabilities is set to receive an investment of 80 million yuan, with a two-year construction period [11]

Group 1 - The core point of the article is that Huafeng Technology (688629.SH) has successfully achieved sample trial qualification for its 224G high-speed backplane connector and has begun project cooperation and communication with major telecommunications clients [1] Group 2 - The company encourages stakeholders to pay attention to subsequent announcements regarding the progress of these collaborations [1]

Group 1: Jingxin Pharmaceutical - Jingxin Pharmaceutical is focusing on the commercialization of Jingnuoning, with over 400 new hospital admissions, covering more than 1,500 hospitals, achieving revenue of 55 million yuan [1] - The company has completed Phase II clinical trials for JX11502 capsules and submitted a market application for Calirazone capsules, while the LP(a) lowering drug is in Phase I [1] - The sales expense ratio has decreased by 2.41 percentage points, and the expense ratio is expected to remain stable [1] - As of July 31, 2025, the company has repurchased shares worth 610 million yuan, primarily for equity incentives [1] - Medical device revenue reached 349 million yuan, a year-on-year increase of 12.01%, while raw material drug revenue was 453 million yuan, a year-on-year decrease of 9.59% due to downstream destocking [1] Group 2: Huafeng Technology - In Q2 2025, Huafeng Technology's production and sales of high-speed line modules showed good growth compared to Q1 [2] - The sales revenue from the new energy vehicle business has increased year-on-year, with an improved product structure and plans to expand market scale for high-voltage connector applications [2] - Asset impairment mainly includes credit impairment losses and inventory write-downs, primarily due to increased accounts receivable and customer cost control [2] - The 224G high-speed backplane connector has completed customer validation testing, with mass production timing dependent on customer demand [2] - The company is collaborating with multiple equipment manufacturers and internet application customers on various projects, with customers generally adopting high-speed line module methods [2]

Core Viewpoint - Huafeng Technology (688629.SH) has completed customer validation testing for its 224G high-speed backplane connectors, with sample availability and mass production timing dependent on customer demand [1] Group 1: Product Development - The company has successfully developed samples of the 224G high-speed backplane connectors [1] - Mass production will be determined based on customer requirements [1] Group 2: Partnerships and Collaborations - Huafeng Technology is collaborating with major equipment manufacturers such as Huawei, Inspur, Super Fusion, Dawn, Huqin, ZTE, and H3C [1] - The company is also engaging with internet application clients including Alibaba, Tencent, and ByteDance for project cooperation [1]